InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Sets Record Date for Litigation-Linked CVR Distribution
This article has been disseminated on behalf of Quantum BioPharma and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that Oct. 27, 2025 has been established as the record date for the distribution of contingent value rights (CVRs) to holders of its Class B Subordinate Voting Shares on a one-for-one basis. Each CVR entitles holders to a pro rata portion of between 10%…